Redcare Pharmacy N.V.
SAEYY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.23 | 2.63 | -2.48 | -0.10 |
| FCF Yield | 0.50% | 0.86% | -10.49% | -1.61% |
| EV / EBITDA | -220.92 | 56.22 | -31.87 | -52.05 |
| Quality | ||||
| ROIC | -4.95% | -1.73% | -10.34% | -9.40% |
| Gross Margin | 23.02% | 24.48% | 27.55% | 25.14% |
| Cash Conversion Ratio | -0.49 | -5.10 | 0.42 | -0.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 25.32% | 19.26% | 7.55% | 14.79% |
| Free Cash Flow Growth | -42.41% | 128.12% | -162.14% | 11.28% |
| Safety | ||||
| Net Debt / EBITDA | -11.67 | 3.15 | -6.16 | 0.28 |
| Interest Coverage | -5.01 | -1.12 | -8.13 | -7.67 |
| Efficiency | ||||
| Inventory Turnover | 11.86 | 10.00 | 8.75 | 8.22 |
| Cash Conversion Cycle | 12.62 | 16.57 | 26.11 | 22.67 |